Stay updated on Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial page.

Latest updates to the Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedFooter updates: addition of 'Revision: v3.3.3' and removal of 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check42 days agoChange Detected- Page revision updated from v3.2.0 to v3.3.2, a minor maintenance update.SummaryDifference0.1%

- Check49 days agoChange DetectedRemoved the site-wide notice about government funding status and NIH operating updates; the NiTraSarc study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check63 days agoChange DetectedThe update appears to be cosmetic updates to the page layout and formatting. There are no changes to the study's purpose, eligibility criteria, primary/secondary outcomes, or scheduling details.SummaryDifference0.4%

- Check91 days agoChange DetectedAdded a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.SummaryDifference3%

- Check99 days agoChange DetectedVersion tag updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.1%

Stay in the know with updates to Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial page.